Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > Analyses

<< Previous

Bullboard Posts

Next >>

Comment by hk1966on May 31, 2022 10:20pm

181 Views

Post# 34722044

RE:RE:RE:RE:RE:RE:RE:RE:RE:Analyses

Quick math based on assumption each Venowave is around 400 retai. Assume sellout price per unit of $200 to DME and purchase cost landed of $100 should get you in the ballpark. Scale from there.2500 units sold as a pair should get 2500x2x100 in gross margin or $500 k in gross margin.I am confident that in the fall they will scale up sales to DMEas the market size in the US alone is potentially 2-10 million units per year based on a rapidly aging population

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?